Literature DB >> 15960119

[Presumption diagnosis: otomycosis. A 451 patients study].

P Hueso Gutiérrez1, S Jiménez Alvarez, E Gil-Carcedo Sañudo, L M Gil-Carcedo García, C Ramos Sánchez, L A Vallejo Valdezate.   

Abstract

Otomycosis is a common disease. We try to analyze the causative factors for otomycosis in our environment. Our study includes 451 patients with a presumed diagnosis of otomycosis. The patients were included by ear, nose and throat specialist and general doctors; the diagnosis was confirmed in 24.43% and 16.16% respectively. The most common fungal pathogen found was Aspergillus spp. and Candida sp. The high frecuency of Aspergillus Niger may be because of the diferent ways of gathering samples. The abundance of Candida parapsilosis in the samples that came from general doctors may be because the inadequate treatment with topic antibiotics contributes fungal proliferation. We conclude that the causative factors for otomycosis could be avoided or treated. Treatment with antifungal agents is not enought to ensure complete cure, an furthermore the treatment should be aimed to restore the physiology of the external auditory cannal.

Entities:  

Mesh:

Year:  2005        PMID: 15960119     DOI: 10.1016/s0001-6519(05)78597-6

Source DB:  PubMed          Journal:  Acta Otorrinolaringol Esp        ISSN: 0001-6519


  11 in total

1.  Otomycosis due to filamentous fungi.

Authors:  Lidia García-Agudo; Pilar Aznar-Marín; Fátima Galán-Sánchez; Pedro García-Martos; Pilar Marín-Casanova; Manuel Rodríguez-Iglesias
Journal:  Mycopathologia       Date:  2011-04-17       Impact factor: 2.574

Review 2.  Otomycosis in iran: a review.

Authors:  Maral Gharaghani; Zahra Seifi; Ali Zarei Mahmoudabadi
Journal:  Mycopathologia       Date:  2015-01-30       Impact factor: 2.574

3.  Otomycosis in central iran: a clinical and mycological study.

Authors:  B Barati; S A R Okhovvat; A Goljanian; M R Omrani
Journal:  Iran Red Crescent Med J       Date:  2011-12-01       Impact factor: 0.611

4.  Type of Antifungals: Does it Matter in Empirical Treatment of Otomycosis?

Authors:  Nagendran Navaneethan; Raj Prakash Dharmapuri YaadhavaKrishnan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-10-04

5.  Otomycosis in a Rural Community Attending a Tertiary Care Hospital: Assessment of Risk Factors and Identification of Fungal and Bacterial Agents.

Authors:  Priti Agarwal; Leimapokpam Sumitra Devi
Journal:  J Clin Diagn Res       Date:  2017-06-01

6.  Otomycosis in Damascus, Syria: Etiology and clinical features.

Authors:  Mohammad T Ismail; Abeer Al-Kafri; Mazen Ismail
Journal:  Curr Med Mycol       Date:  2017-09

7.  Etiologic Agents of Otomycosis in the North-Western Area of Iran.

Authors:  Abdolhassan Kazemi; Maryam Majidinia; Abbasali Jaafari; Seyyed Amin Ayatollahi Mousavi; Ali Zarei Mahmoudabadi; Hossein Alikhah
Journal:  Jundishapur J Microbiol       Date:  2015-09-08       Impact factor: 0.747

8.  Effectiveness of 7.5 percent povidone iodine in comparison to 1 percent clotrimazole with lignocaine in the treatment of otomycosis.

Authors:  Ajay Philip; Regi Thomas; Anand Job; V Rajan Sundaresan; Shalini Anandan; Rita Ruby Albert
Journal:  ISRN Otolaryngol       Date:  2013-07-25

9.  Assessment of Response to Treatment in Patients with Otomycosis.

Authors:  Keyvan Kiakojori; Nasim Bagherpour Jamnani; Soraya Khafri; Saeid Mahdavi Omran
Journal:  Iran J Otorhinolaryngol       Date:  2018-01

10.  Identification of Fungal Pathogens in Otomycosis and Their Drug Sensitivity: Our Experience.

Authors:  Khaled Ali; Mahmood A Hamed; Hameda Hassan; Amira Esmail; Abeer Sheneef
Journal:  Int Arch Otorhinolaryngol       Date:  2018-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.